アンジェス MG｜4563｜
Contents
1. 2014 3 HGF Www sharedre2. tia HGF ie HGF HGF 2001 2002 I II 2003
3. 2 3 3 5 3 7 1 T 2013 R amp D 2006 2008
4. VOYAGE GROUP HD
5. HGF 2014 11 2017 HGF Weaknesses PP HGF 2014 9 6 088 2014 12 6 017 2015 12
6. J GCA DIC TOKALD
7. SR Inc SR Inc Shared Research inc 3 31 12 http www sharedresearch jp TEL 03 5834 8787 Email info sharedresearch jp Shared eSeafch 37 37 www sharedresearch jD
8. www sharedresearch jD Shared eseatche 34 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 10 SBI 3 90 2 21 1 2 12 1 61 1 47 1 29 0 989 0 91 0 81 0 77 SR 2014 12 www sharedresearch jD Shared eSeafCh 35 37 R Shared Research Report MG gt Nd NO
9. HVJ E MG Allovectin 7 VI Naglazyme VI Naglazyme FDA SPA FDA
10. 10 155 1 735 9 134 1 021 100 100 1 021
11. 2013 12 NF kB 2014 12 HGF 22 37 www sharedresearch jD R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 SR 5
12. 3 2014 10 500 3 2018 2014 9 4 HGF BB HGF
13. NF kB NF kB 2015 3 1 2017 2018 CIN 2016 CIN 2016 www sharedresearch jD Shared eseatch 10 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28
14. 25 28 28 SAN 29 SS 36 Www sharedresearch jp Shared Gcseareh 02 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 HGF 1999 HGF 2001 12
15. 120 2007 6 40 HGF Fontaine IV 4 2 8 12 12 HGF 70 49 6 19 27 30 89 4 13 p 0 014 FontaineIV
16. 8 1 9 22 gt 32 403 900 32 403 900 1 288 2014 9 5 9 30 9 29 2014 7 31 2014 8 1 Vy Vv VV VY 100 gt 9 332 gt 198 9 134 9 134 2013 5
17. 6 2015 12 7 8 12 ii Di 12 000 EE 14 EE 22 SW Strengths Weaknesses 24
18. NF kB BO MD NF kB I II SR 2015 12 HGF HGF CIN 15 12 16 12 17 12 18 12 19 12 ii 2 0 NN HGF ES a a CN EN i EE 0 i 1 RT SR HGF
19. MG Aiming SBS KLab
20. NF kB PTA PTA NF kB PTA PTA 2016 31 5 NF kB NF kB 2013 3 2014 12
21. SR HGF 3 HGF SW Strengths amp Weaknesses www sharedresearch jD Shared eseatch 03 37 R Shared Research Report A NC 4563 MG gt LAST UPDATE 2015 09 28 07 12 08 12 09 12 10 12 11 12 12 12 13 12 14 12 15 12 1 720 951 586 287 243 445 491 910 450 40 9 44 79 38 49 51 0 15 2 82 6 10 5 85 2 50 596 2 040 2 685 2 611 2 010 2 101 1 785 1 363 2 274 5 800 8 gt
22. 3 4 5 9 6
23. 2012 10 HGF HGF 2015 12 2015 2 6 2015 12 2015 5 2015 5 25 2015 3 20 2 4 5 6 2015 3 20 5 6
24. www sharedresearch jD eShat esearch 30 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 I WM 10 000 000 2014 12 18 68 2015 3 20 2015 7 31
25. HGF 2012 10 HGF 2015 6 HGF HGF HGF HGF
26. PP Neovasculgen 2011 9 The Russian Ministry of Healthcare and Social Development 2012 9 VEGF Vascular Endothelial Growth Factor 2 ViroMed Co Ltd HGF VM202 PAD www sharedresearch jD Shared eseatche 17 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 ViroMed 2014 IT HGF 1 4508 2015 5
27. SR Inc SR Inc Shared Research SR Inc SR Inc SR Inc SR Inc
28. 2007 12 615 2008 12 2013 1 CRO Contract Research Organization HGF 2006 12 1 920 2007 12 2013 12 274 HGF 2014 12 3 2014 12 3 4 2015 12 50 2016 12 2017 12 30 2018 12 HGF
29. 2015 5 HGF 3 200 10 28 1 21 50 9 HGF 2013 10 L 2016
30. SR 2014 10 2014 12 4 3 4 2018 2018 SR 2019 2019 2020 HGF 55 1 000
31. KS 2015 3 20 EVO FUND 2015 3 20 2015 7 31 4 10 000 000 2
32. NF kB 2015 3 2015 3 24 25 Ce HGF NEDO 25 69 2015 12 1 2015 12 2015 3 20
33. 1 2015 2016 www sharedresearch jD Shared eseatche 33 37 R Shared Research Report a CC 4563 MG gt LAST UPDATE 2015 09 28 2014 7 2014 7 22
34. 2010 9 HGF 2011 12 2012 12 2012 12 HGF 2018 12 2010 2012 10 HGF 2013 3 370 2013 5 1 989 2013 8 HGF 2014 2 2014 9
35. 6 B 1 2015 2016 2016 2013 11 2014 B A B B HGF 50
36. 26 2014 7 22 2014 9 30 65 24 21 140 6 088 2014 9 30 53 544 14 847 2014 9 2014 9 22 15 FDA SPA
37. CIN2 3 10 15 7 10 T 900 22 6
38. 500 2025 2019 HGF HGF www sharedresearch jD sShar eSeafch 31 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 NF kB 2015 5 2015 2016 2017 2018 2019 HGF EU EU a HIGF P1 2 NF kB oo 40
39. 2006 I 2009 11 FDA SPA Special Protocol Assessment 2010 9 PMDA i 2010 9 Fast Track Fast Track FDA 2012 7 HGF 2014 10
40. 109 21 2 633 237 95 1 709 137 1 513 2 7 a 31 14 2 049 946 2 121 946 NEDO 61 96 118
41. 2003 5 HGF IL 2006 6 Www sharedresearch jp Shared eseatche 15 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 HGF TcPOz PMP HGF HGF HGF 2007 2010 HGF
42. 2014 5 I NF kB 2013 3 15 2013 8 6 www sharedresearch jD Shared eSeafCh 27 37 R Shared Research Report CC 4563 MG gt
43. 67 46 6 1 19 77 909 I 2001 12 2015 5 VI 200 300 www sharedresearch jD sShared eS atche 12 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 y gt
44. gt HGF HGF 2014 10 2018 2019 HGF 300 400 HGF HGF 2007 2008 HGF PMDA
45. 1 2014 11 6 500 15 HGF 3 4 2017 2018 HGF 80 HGF 1
46. 2 4 2 4 5 6 2015 3 20 5 6 www sharedresearch jD Shared eSeafCh 29 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 SR NF kB
47. p www sharedresearch jD Shared eseatche 20 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 Orphan Drug VI VI
48. 64 HGF FDA 2013 3 SPA 2013 11 HGF www sharedresearch jD Shared eseatche 26 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 NF kxB NF kB 2011 3 2013 6
49. CIN 0 SR HGF HGF 1984 HGF Hepatocyte Growth Factor 1984 1995 HGF HGF HGF HGF www sharedresearch jD Shared eSeafCh 14 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28
50. www sharedresearch jD Shared eSeafCh 11 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 1999 HGF HGF DNA
51. 55 HGF No Option Poor Option 20 50 EIC No option patients Poor option patients HGF 1 000 HGF 2015 5 HSCI Human Stem Cells Institute Neovasculgen ViroMed HGF VM202 PAD NV1FGF FGF1
52. 2006 5 2013 0 a
53. NEDO 69 EVO FUND 8 884 439 2014 12 2014 12 910 85 2 309 13 7 601 183 1 VI HGF
54. 2015 3 20 1 2 2015 4 24 3 4 3 2015 7 31 5 6
55. HGF 2012 10 3 184 21 2 151 15 1 HGF 920 255 98 2 339 128 3 694 0 7 34 2 274 1 363
56. HGF 100 09 6 11 11 40 09 2 5 p 0 018 Fontaine 4 1 1 TW TV HGF 2008 3 HGF PMDA 2010 9 PPM II
57. HGF HGF HGF 2013 3 370 2013 5 1 989 2014 9 6 088 2014 4 491 NF kB 2015 3
58. 2015 2016 HGF www sharedresearch jD sShared eSeafCh 09 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 2016 HGF 2015 6 HGF 2012 10 HGF
59. 2015 5 HGF HGF NF kB NF kB NF kB NF xB PTA Percutaneous Transluminal Angioplasty www sharedresearch jD Shared eSeafCh 18 37 R Shared Research Report a CC 4563 MG gt LAST UPDATE 2015 09 28
60. 2016 FDA IND 1 2 CIN cervicalintraepithelial neoplasia CIN CIN CIN BL 2013 4 BL CIN CIN HPV HPV
61. HPV www sharedresearch jD Shared eseatche 19 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 CIN 2009 1 2 2 1 CIN 3 10 2 7 17 70 9 CIN 3 CIN 2
62. 6 088 HGF 2018 12 www sharedresearch jD Shared eSeafCh 13 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 O HGF NF kB CIN H GF a PTA SR
63. 3 5 y y 3 523 NF kB NF kB 2015 2016 2017 2018 2019 10 813 2015 8 10 2015 8 3 2015 12 2 2015 12 2 3 amp www sharedresearch jD Shared eSeafCh 05 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 14 12 15 12
64. SR 30 40 HGF HGF SR HGF HGF 2017 HGF 2013 10 2017 2015 5
65. 30 1 10 B 1 2007 8 2008 3 2008 4 www sharedresearch jD Shared eSeafCh 21 37 MG 4563 R Shared Research Report MG gt LAST UPDATE 2015 09 28 09 12 10 12 11 12 12 12 13 12 586 287 243 445 491 910 142 181 181 242 271 309 15 8 444 106 63 187 212 601 3 197 2 297 2 344 2 230 1 854 3 183 68 83 81 129 131 50 2 350 1 440 1 444 1 200 1 025 2 338 503 420 348 2 247 309 1 062 315 348 374 274 1 194
66. 92 1 1 250 000 2 6 1 750 000 EVO FUND VV VV gt 2 750 gt 33 gt 2 717 1 2 6 1673 EE NF kB 2015 2 2015 2 6 MG 2025 2025 HGF NF kB
67. 2 005 1 036 1 944 999 NEDO 72 12 7 2 040 969 92 www sharedresearch jD Shared eSeafCh 06 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 2015 12 14 12 15 12 910 450 3 184 151 2 339 694 2 274 5 800 2 395 5 800
68. 2 369 5 800 SR 2015 12 450 5 800 VI HGF 601 2015 12
69. NF kB NF kB 2015 3 1 200 2016 2017 2018 280 1 000 NF kB
70. 779 775 819 901 699 693 104 123 123 121 72 74 218 217 230 224 139 125 183 135 145 197 197 163 2 611 2 010 2 101 1 785 1 363 2 274 SR 09 12 10 12 11 12 12 12 13 12 500 289 102 42 159 35 92 89 97 90 132 151 148 53 83 91 110 120 161 26 113 8 2 50 SR 2014 12 33 9 66 1
71. 1 731 2 541 2 784 1 911 1 791 1 716 1 383 2 395 5 800 5 8 5 1 728 3 534 2 921 1 967 1 815 1 708 1 410 2 369 5 800 es err 23 443 23 550 23 598 23 646 24 467 26 226 31 268 53 544 EPS 5 8 150 4 124 0 83 3 4 6 67 7 46 9 62 1 108 3 EPS DPS 522 9 378 1 271 7 175 1 125 8 60 3 107 9 142 4 Pe 9 978 7 301 5 047 3 053 1 576 355 2 295 6 017 11 471 8 310 5 935 4 143 2 635 1 342 3 305 7 594 112 96 61 72 62 45 23 28 1 210 991 954 633 1 050 770 506 508 390 282 212 15 142 103 70 54 13 182 9 678 7 162 5 004 3 889 2 260 3 904 8 184 109 7 49 98 60 67 42 207 g 664 606 515 488 417 331 218 116 877 715 649 716 601 507 345 423 17 15 15 15 17 15 15 26 877 715 649 716 618 522 361 449 12 306 8 964 6 513 4 288 3 271 1 739 3 544 7 734 1 976 1 978 2 225 1 843 1 706 1 631 1 457 2 704
72. 2010 i i 2014 2 HGF 2019 lt 2020 HGF HGF 50 1 000 SR 30 40 2015 12 450 5 800 2014 12 HGF NF kgB
73. 3 668 1 527 531 952 768 7 27 52 7 446 387 3 390 6 427 RO A ROE 8 6 93 396 92 69 90 99 85 796 84 19 76 99 90 8 94 5 SR www sharedresearch jD 04 37 R Shared Research Report MG 4563 MG gt LAST UPDATE 2015 09 28 2015 9 28 MG p 15 501 2015 8 31 27 4 2015 10 13 2015 10 15 2015 10 20 2015 10 22 y 1 999 2015 8 31
74. 2 400 2 600 2 400 2 400 2 600 2 400 VI www sharedresearch jD Shared eseatche 32 37 R Shared Research Report a CC 4563 MG gt LAST UPDATE 2015 09 28 2014 10 2014 10 1
75. 82 1 0 74 34 3 8 72 1 1 043 86 5 36 33 0 HGF 278 53 760 110 6 246 44 1 24 18 961 476 881 437
76. 2 395 1 383 NEDO www sharedresearch jD Shared eseatche 25 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 61 115 137 2 369 1 410 a 9 CS 2014 12 3 2014 12 3 282 28 0 222 18 7 60 69 5 2 330 74 2
77. 13 2 091 972 2013 12 491 10 5 NF kB VI NF kB cE Pe 271 12 3 212 13 3 7 51 0 1 024 14 6 100
78. ee es Gai NF kB 9 9 NF kB nr NM 2 14 Ge i CIN ac Is oni gt HGF HGF NF kB CIN 2015 2 2 2014 12 2014 12 900 750 850 2 400 2 600 2 400
79. 87 4 2015 6 HGF 2 246 85 5 87 28 4 HGF NF kB 623 95 1 711 109 5 448 37 3 25 24 17
80. NN 4 MG 072 643 3590 1999 12 17 HP https www anges mg Com index Dhp IR IR www sharedresearch jD Shared MG 4563 LAST UPDATE 2015 09 28 To67 0085 7 15 4 2002 9 25 12 IR https www anges mg com ir index php IR 03 5730 2641 eSeafch 36 37 R Shared Research Report SR
81. 15 12 2Q 3Q 2Q 3Q 83 92 107 628 82 158 53 4 450 34 396 51 49 40 59 528 396 1 0 72 596 559 651 1120 853 1 043 1 203 23 0 32 0 187 5 65 1 86 596 84 796 476 560 1 013 225 961 1 045 5 800 0 6 8 437 5962 gt 122 92 881 1 063 5 800 6 8 8 439 530 1 122 279 884 1 156 5 800 8 SR 2015 12 2 2015 12 2 240 37 7 VI 171 24 4 1 6 69
82. 1999 12 2000 8 2001 1 2001 10 2001 10 2002 4 2002 6 2002 7 2002 9 2003 9 2004 3 2006 5 2006 12 2008 4 2009 11 2010 9 2012 10 2013 1 www sharedresearch jD LAST UPDATE 2015 09 28 HVJ E HGF HGF
83. Fast Track Shared WeseafcH 28 37 R Shared Research Report a CC 4563 MG gt LAST UPDATE 2015 09 28 amp 2015 6 2015 6 23 1 4508 2015 2 17 2015 6 22 2015 12 2
84. 12 2018 12 4 HGF NF kB 2015 12 50 2016 12 2017 12 30 2018 12 HGF SR 2015 12 5 800 SR 2019 12 HGF 2019 12
85. 2015 5 734 400 HGF A 1 HGF Www sharedresearch jp sShared eS atche 08 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 cis 2013 2018 491 1 1I6 088 HGF
86. HGF 2015 12 HGF NF kxB 5 000 2014 12 www sharedresearch jD Shared ese atche 07 37 R Shared Research Report a CC 4563 MG gt LAST UPDATE 2015 09 28 HGF 2015 2 2025 2025 500 1 2019 2015 12 2018 12 2015
87. 2015 5 PP 2015 2 2025 2019 2025 50 000 2019 HGF HGF NF kB HGF 2007 2008 PMDA Pharmaceuticals and Medical Devices Agency
88. 5 800 PP 5 6 15 10 2015 5 HGF 2015 5 HGF PWM HGF SR www sharedresearch jD Shared eseatch 24 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 2015 12 1 2015 12 1
89. SR 2012 12 3 2013 1 2012 12 901 2014 12 693 www sharedresearch jD Shared eSeafCh 23 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 SW Strengths Weaknesses Strengths HGF 2007 2006 6 HGF
90. LAST UPDATE 2015 09 28 MG 4563 Research Report by Shared Research Inc sr_inquiries sharedresearch jp R Shared Research Report MG 4563 LAST UPDATE 2015 09 28
91. search jp Shared eseatche 16 37 R Shared Research Report CC 4563 MG gt LAST UPDATE 2015 09 28 SR HGF 2010 9 2013 11 2014 10 1 2015 6
Download Pdf Manuals
Related Search